Neoplasms, Mesothelial  >>  Caprelsa (vandetanib)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Caprelsa (vandetanib) / Sanofi
NCT00597116 / 2007-003633-16: An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma

Terminated
2
25
Europe
Vinorelbine, Navelbine®, Vandetanib, ZD6474, ZACTIMA™
Genzyme, a Sanofi Company
Mesothelioma
01/10
01/10

Download Options